670 likes | 1.15k Views
Post-infectious glomerulonephritis. Stephen Marks Consultant Paediatric Nephrologist Great Ormond Street Hospital for Children and UCL Institute of Child Health, London, UK. Nephrology for the General Paediatrician, Manchester Friday 22 June 2012. Summary. Case presentation
E N D
Post-infectious glomerulonephritis Stephen Marks Consultant Paediatric Nephrologist Great Ormond Street Hospital for Children and UCL Institute of Child Health, London, UK. Nephrology for the General Paediatrician, Manchester Friday 22 June 2012
Summary • Case presentation • Causes • Management • Prognosis
Case presentation • 15-year old Afro-Caribbean boy • 1 week history of abdominal, leg and facial swelling with increasing shortness of breath • he and his siblings have had a few ?viral infections with sore throat over the last 3 winter months • no rash but reduced oral intake over last 24 hours with oliguria • On examination • unwell with weight on 25th centile and height on 2nd centile • capillary refill time of 2 seconds with palpable peripheral pulses • prominent apex beat, BP = 152/94 mmHg • tachypnoeic with lung crepitations in all areas • generalised oedema and ascites
Hb 12.0 g/dl WCC 12.3 x 109/l Platelets 325 x 109/l Sickle screen -ve Sodium 130 mmol/l Potassium 7.2 mmol/l Chloride 108 mmol/l tCO2 14 mmol/l Urea 24.8 mmol/l Creatinine 258 µmol/l Calcium 1.8mmol/l Albumin 24g/l Phosphate 1.6 mmol/l ALP 160 U/l ALT 24 U/l Bilirubin 12 µmol/l Urinary dipstick proteinuria ++++ haematuria ++ CXR normal heart size pulmonary oedema Renal ultrasound two big echobright kidneys Investigations
Question (a) • Which two of the following are the best descriptions of his clinical condition ? A. Acute renal failure / acute kidney injury B. Acute on chronic renal failure C. Chronic renal failure or chronic kidney disease D. End-stage renal failure E. Neither nephritic nor nephrotic syndrome F. Nephritic syndrome (but not nephrotic syndrome) G. Nephrotic syndrome (but not nephritic syndrome) H. Nephritic and nephrotic syndrome
Question (b) • In which range is this patient’s corrected calcium in ? A. 1.71 - 1.8mmol/l B. 1.81 - 1.9mmol/l C. 1.91 - 2.0mmol/l D. 2.01 - 2.1mmol/l E. 2.11 - 2.2mmol/l
Question (c) • Which of the following would not be part of an effective management plan for his hyperkalaemia ? • Calcium carbonate • Calcium gluconate • Calcium resonium • Cardiac monitor • Furosemide • Insulin and dextrose infusion • Salbutamol • Sodium bicarbonate
Question (d) • How would you treat his hypertension ? • Intravenous 4.5% albumin infusion • Intravenous 20% albumin infusion and furosemide • Intravenous furosemide • Intravenous labetalol • Low salt diet • Oral amlodipine • Oral atenolol • Oral enalapril • Oral furosemide • Oral nifedipine
Question (e) • Despite initial fluid and medical management, he becomes anuric for 48 hours and his plasma creatinine increases to 512µmol/l • What one investigation would you do to help make the diagnosis ? • ANA and anti-dsDNA • Anti-GBM antibody • Anti-streptolysin O and anti-DNAase B titres • Auto-immune screen • Blood film • C3, C4 and auto-antibody screen • Immunoglobulin levels • Renal biopsy
Question (f) • What is the most likely diagnosis ? • Haemolytic uraemic syndrome • Minimal change nephrotic syndrome • Post-infectious glomerulonephritis • Renal venous thrombosis • Sickle nephropathy
Question (a) • Which two of the following are the best descriptions of his clinical condition ? A. Acute renal failure / acute kidney injury B. Acute on chronic renal failure C. Chronic renal failure or chronic kidney disease D. End-stage renal failure E. Neither nephritic nor nephrotic syndrome F. Nephritic syndrome (but not nephrotic syndrome) G. Nephrotic syndrome (but not nephritic syndrome) H. Nephritic and nephrotic syndrome
Question (a) • Which two of the following are the best descriptions of his clinical condition ? A. Acute renal failure / acute kidney injury B. Acute on chronic renal failure C. Chronic renal failure or chronic kidney disease D. End-stage renal failure E. Neither nephritic nor nephrotic syndrome F. Nephritic syndrome (but not nephrotic syndrome) G. Nephrotic syndrome (but not nephritic syndrome) H. Nephritic and nephrotic syndrome
Question (b) • In which range is this patient’s corrected calcium in ? A. 1.71 - 1.8mmol/l B. 1.81 - 1.9mmol/l C. 1.91 - 2.0mmol/l D. 2.01 - 2.1mmol/l E. 2.11 - 2.2mmol/l
Question (b) • In which range is this patient’s corrected calcium in ? A. 1.71 - 1.8mmol/l B. 1.81 - 1.9mmol/l C. 1.91 - 2.0mmol/l D. 2.01 - 2.1mmol/l E. 2.11 - 2.2mmol/l
Corrected calcium • How do you calculate corrected calcium from total calcium result ? • Corrected calcium = Total calcium + [(40 - Patient’s albumin (g/l)) x 0.025] • Some sources use correction factor of 0.02 instead of 0.025
Corrected calcium • Corrected calcium = Total calcium + [(40 - Patient’s albumin (g/l)) x 0.025] • For this case, corrected calcium = 1.8mmol/l + [(40 - 24) x 0.025] = 1.8mmol/l + (16 x 0.025) = 1.8mmol/l + 0.4 = 2.2mmol/l
Question (c) • Which of the following would not be part of an effective management plan for his hyperkalaemia ? • Calcium carbonate • Calcium gluconate • Calcium resonium • Cardiac monitor • Furosemide • Insulin and dextrose infusion • Salbutamol • Sodium bicarbonate
Question (c) • Which of the following would not be part of an effective management plan for his hyperkalaemia ? • Calcium carbonate • Calcium gluconate • Calcium resonium • Cardiac monitor • Furosemide • Insulin and dextrose infusion • Salbutamol • Sodium bicarbonate
Question (d) • How would you treat his hypertension ? • Intravenous 4.5% albumin infusion • Intravenous 20% albumin infusion and furosemide • Intravenous furosemide • Intravenous labetalol • Low salt diet • Oral amlodipine • Oral atenolol • Oral enalapril • Oral furosemide • Oral nifedipine
Question (d) • How would you treat his hypertension ? • Intravenous 4.5% albumin infusion • Intravenous 20% albumin infusion and furosemide • Intravenous furosemide • Intravenous labetalol • Low salt diet • Oral amlodipine • Oral atenolol • Oral enalapril • Oral furosemide • Oral nifedipine
Question (e) • Despite initial fluid and medical management, he becomes anuric for 48 hours and his plasma creatinine increases to 512µmol/l • What one investigation would you do to help make the diagnosis ? • ANA and anti-dsDNA • Anti-GBM antibody • Anti-streptolysin O and anti-DNAase B titres • Auto-immune screen • Blood film • C3, C4 and auto-antibody screen • Immunoglobulin levels • Renal biopsy
Question (e) • Despite initial fluid and medical management, he becomes anuric for 48 hours and his plasma creatinine increases to 512µmol/l • What one investigation would you do to help make the diagnosis ? • ANA and anti-dsDNA • Anti-GBM antibody • Anti-streptolysin O and anti-DNAase B titres • Auto-immune screen • Blood film • C3, C4 and auto-antibody screen • Immunoglobulin levels • Renal biopsy
Question (f) • What is the most likely diagnosis ? • Haemolytic uraemic syndrome • Minimal change nephrotic syndrome • Post-infectious glomerulonephritis • Renal venous thrombosis • Sickle nephropathy
Question (f) • What is the most likely diagnosis ? • Haemolytic uraemic syndrome • Minimal change nephrotic syndrome • Post-infectious glomerulonephritis • Renal venous thrombosis • Sickle nephropathy
Hypocomplementaemia • Immune-complex mediated disorders • infective endocarditis • shunt nephritis • activation of the complement pathway and resulting hypocomplementaemia • MPGN (but not FSGS) associated with low C3 • RPGN is a clinical diagnosis and is not necessarily hypocomplementaemic
Post-infectious glomerulonephritis - 1 • Post-streptococcal GN • prototype for bacterial infection-related GN (PIGN) with antecedent pharyngeal (7 - 15 days) or cutaneous infection (eg. impetigo; 4 -6 weeks) • caused by nephritogenic strain of Streptococci • NATURE OF NEPHRITOGENIC ANTIGEN DEBATED • <50% complete remission on long follow-up of immunocompromised adults with atypical PIGN • Moroni G, Ponticelli C (2009)
Post-infectious glomerulonephritis - 2 • Incidence and spectrum changing • epidemic form declined in industrialised countries • post-streptococcal glomerulonephritis = 28 - 47% of acute GN • Staph aureus / epidermidis = 12 - 24% • Gram negative bacteria = 10 - 22% • others • inc. bacterial endocarditis, shunt infections, atypical PIGN • acute endocapillary glomerulonephritis with mesangial and capillary granular immune deposition • Montseny JJ et al (1995) Medicine (Baltimore) • Moroni G et al (2002) Nephrol Dial Transplant • Nasr SH et al (2008) Medicine (Baltimore)
Clinical course of PIGN • Acute GN < 2 weeks • Massive proteinuria in <4% of PSGN children • Severe end of spectrum with RPGN • histopathologically crescentic GN • Resolution of hypocomplementaemia (C3) • by 8 - 10 weeks
Post-infectious glomerulonephritis • The indications for renal biopsy are • severe renal dysfunction at presentation • rapidly progressive acute renal failure • atypical presentation • delayed recovery • macroscopic haematuria for >1 month • low C3 levels for >6 months • heavy proteinuria for > 6 months • Note that microscopic haematuria can persist for years following the acute episode
Treatment of PIGN • Supportive treatment • management of fluids and electrolytes • acute (and chronic) treatment of hypertension, oedema, congestive cardiac failure and proteinuria • Specific treatment • antibiotics are unhelpful for reversing GN as established glomerular lesions induced by immune complexes • penicillin (or erythromycin if allergic) • to resolve well-documented streptococcal infection • to prevent spread of nephritogenic streptococcus in contacts • no RCT but intravenous methylprednisolone if extensive glomerular crescents and RPGN • based on extrapoloation from other causes of RPGN
Nephritic syndrome Nephrotic syndrome Mixed nephritic and nephrotic
Nephritic syndrome Haematuria Proteinuria Oliguria Hypertension Nephrotic syndrome Mixed nephritic and nephrotic
Nephritic syndrome Haematuria Proteinuria Oliguria Hypertension Nephrotic syndrome Proteinuria > 40mg/m2/hour > 1g/m2/day Hypoalbuminaemia < 25g/l Oedema (Hyperlipidaemia) Mixed nephritic and nephrotic
Nephritic syndrome Commonest cause PIGN / PSGN or post-infectious glomerulonephritis Nephrotic syndrome Commonest cause MCD / MCNS or minimal change nephrotic syndrome Mixed nephritic and nephrotic
Nephritic syndrome Commonest cause PIGN / PSGN or post-infectious glomerulonephritis Nephrotic syndrome Commonest cause MCD / MCNS or minimal change nephrotic syndrome Mixed nephritic and nephrotic Commonest cause of mixed nephritic and nephrotic syndrome is post-infectious GN
Prerenal • Renal • Postrenal
Clinical features - Examination • State of patient • Routine observations • temperature, HR, SBP, RR, SaO2, AVPU (GCS) • core-peripheral temperature • Serial plot of weights, heights and OFC • State of hydration • peripheral perfusion, JVP, oedema • Signs of cardiac failure • Clinical clues of multi-system disease • rash, arthropathy, arthritis, oral lesions • Palpable kidneys or bladder or masses
Investigations – Blood tests (1) • Full blood count, blood film and ESR • Coagulation screen • Cross-match • Serum electrolytes • U&Es, Cl, CO2, urea, creatinine, glucose • LFTs, CK, urate, bone profile • Ca, Mg, PO4, ALP, albumin • Blood culture and CRP
Investigations – Blood tests (2) • Complement assays • C3, C4 and C3 nephritic factor • Immunoglobulins including IgA • ASOT and antiDNAase B • ANA, dsDNA, qDNA, ENA, ANCA, ACIgM/G • Autoimmune profile and anti-GBM Ab
Investigations – Urine tests • Urinalysis • Urine M,C&S • Urine electrolytes • Fractional excretion of sodium (FENa) = UNa x PCr————— PNa x UCr
Urine electrolytes in ARF • Only on patients NOT on diuretics Test Prerenal Renal Na <20 >20 Urea >250 <150 U:P urea >20 <10 U:P Cr >20 <15 Sediment Nil ? Sediment
Investigations – Other tests • Renal ultrasound scan • bilateral echogenic kidneys • Percutaneous renal biopsy • confirm PIGN • exclude MPGN • consider crescentic GN
Investigations – Ongoing tests • U&Es, CO2 and creatinine • frequency determined by clinical picture and may be appropriate to perform up to every 6 hours • Ca, PO4, Mg, albumin, ALP (at least daily) • FBC daily • Urinalysis daily • Urine electrolytes daily (unless on diuretics)
Patient Progress - 1 • Further fluid boluses of crystalloid or colloid +/- furosemide as indicated by clinical state of hydration and urine output • Monitoring • daily or twice daily weights • accurate input-output recording • at least 4 hourly BP • at least 4 hourly monitoring of peripheral-core temperature gradient
Patient Progress - 2 • Ongoing fluid management • initially simplest plan is to give insensible losses (400 ml/m2/day or 30 ml/kg/day) and replace UO • GIVE 100% URINE OUTPUT (UO) IF EUVOLAEMIC • RESTRICT TO 50-75% UO IF OVERLOADED • MODIFIED TO FLUID RESTRICTION IF ON DIALYSIS OR URINE OUTPUT ESTABLISHED • In polyuric recovery phase • replace urine output with insensible losses for 24 hours, then set fluid target if renal function continuing to improve
Multidisciplinary team • Doctors • Nurses • Pharmacists • Dietitians • Play therapists • Social worker • Psychosocial team